Cross-sectional analysis revealed high rates of carbapenem-resistant Klebsiella pneumoniae, indicating significant antibiotic resistance issues.
Background: Resistance to antibiotics is a prominent issue in treating infections caused by Klebsiella pneumoniae. Objectives: The present study aimed to investigate the prevalence of carbapenem and colistin-resistant (ColR) K. pneumoniae and their molecular characteristics in a hospitalized patient in Tehran, Iran. Methods: This cross-sectional study was performed on K. pneumoniae isolated from different wards of a hospital during 2020 - 2021. Following the biochemical identification of the isolates, their antibiotic resistance was evaluated. Genes of blaCTX-M, blaNDM, blaOXA-48, blaKPC, and mcr-1 were identified in isolates by PCR. The data were analyzed using SPSS software. Results: A total of 380 isolates of K. pneumoniae were collected, of which 275 (72.3%) were extended-spectrum beta-lactamase (ESBL) producers, among which 49.4% (n = 136/275) were carbapenemase producers, and 62.5% (n = 85/136) were ColR. blaOXA-48 and blaNDM were the dominant genes. There was a significant correlation between the high prevalence of the blaNDM gene and ColR isolates (P = 0.038). Conclusions: Our findings revealed the high prevalence of carbapenem-resistant isolates, likely due to the excessive clinical use of carbapenems in hospitals. The high prevalence of the blaNDM gene in ColR carbapenem-resistant Klebsiella pneumoniae (CRkP) isolates could indicate the high incidence of a specific clone that contributes to the simultaneous acquisition of resistance genes among patients.
No takes yet. Share an insight, caveat, or question.
Barkhordari et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: